Barometers trade with tiny cuts; auto shares gear up

Image
Last Updated : Nov 27 2024 | 10:50 AM IST
The domestic equity benchmarks traded near the flatline with some negative bias in morning trade. The Nifty traded below the 24,200 level. Auto shares advanced after declining in the previous trading session.

At 10:30 ST, the barometer index, the S&P BSE Sensex was down 25.75 points or 0.03% to 79,978.31. The Nifty 50 index lost 10.30 points or 0.04% to 24,184.20.

In the broader market, the S&P BSE Mid-Cap index rose 0.04% and the S&P BSE Small-Cap index added 0.64%.

The market breadth was strong. On the BSE, 2,324 shares rose and 1,221 shares fell. A total of 165 shares were unchanged.

New Listing:

Shares of NTPC Green Energy were currently trading at Rs 119.85 at 10:14 IST on the BSE, representing a premium of 10.97% as compared with the issue price of Rs 108.

The scrip was listed at Rs 111.60, exhibiting a premium of 3.33% to the issue price.

So far, the stock has hit a high of 119.90 and a low of 111.60. On the BSE, over 125.44 lakh shares of the company were traded in the counter so far.

Buzzing Index:

The Nifty Auto index rose 0.39% to 23,504.75. The index fell 1.07% in the previous trading session.

Exide Industries (up 1.86%), Mahindra & Mahindra (up 1.07%), Ashok Leyland (up 0.84%), Maruti Suzuki India (up 0.83%) and Bajaj Auto (up 0.8%), Tata Motors (up 0.7%) added.

On the other hand, Apollo Tyres (down 1.62%), Balkrishna Industries (down 0.96%) and Samvardhana Motherson International (down 0.77%) turned lower.

Stocks in Spotlight:

Aster DM Healthcare gained 3.55% after the company entered into an agreement with Aster Adhaar Hospital (Prerana Hospital) to acquire an additional 13% stake in Aster Adhaar Hospital (Prerana Hospital) in Kolhapur, Maharashtra.

CG Power and Industrial Solutions added 2.07% after the companys subsidiary G.G.Tronics India (GGT) secured a KAVACH order from Chittaranjan Locomotive Works, West Bengal, Government of India.

Glenmark Pharmaceuticals shed 0.34%. The company has announced that its US-based subsidiary, Glenmark Pharmaceuticals Inc., USA, has launched Travoprost Ophthalmic Solution USP (Ionic Buffered Solution) in the U.S. market.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 27 2024 | 10:31 AM IST

Next Story